Arphra/Issuer/LH

LH

Labcorp Holdings Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$257.73

+0.53%LiveJun 01, 2026

AI Brief

Market cap

$21.13B

52w range

241.81 – 293.72

P / E

—

EPS

—

Volume

168.56K

Revenue · FY

$13.95B

+7.25% YoY

Explain this page

Arphra AIPlain-English read on Labcorp Holdings Inc.’s valuation

Total filings

Last ~200

YTD

2026

8-Ks · 12mo

Current reports

Last filing

—

AI · Disclosure analysis

Arphra AI

Click Analyze filings to have Arphra AI review the last 80 SEC filings for LH and return: a one-paragraph summary of recent disclosure activity, 3-5 thematic patterns, 3-5 notable individual filings worth flagging, and 2-3 watch items.

M&A activity

4DB

Whole-company transactions where LH is acquirer or target.

Date	Role	Counterparty	Filing
Nov 26, 2014	Acquirer	Cravath	SEC →
Apr 25, 1995	Acquirer	NantHealth, Inc.	SEC →
Mar 30, 1995	Acquirer	NantHealth, Inc.	SEC →
Mar 14, 1994	Acquirer	Rule	SEC →

No filings in last 5 years.

Form-type mix

No data.

All 8-K · Current reports 10-K · 10-Q Proxy & ownership Registration Other

0 filingsDB · sec_filings

Filed	Accepted	Form	Description	Link
No filings in this group.